Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
RNA Interference01:23

RNA Interference

26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Nucleic Acid Structure01:25

Nucleic Acid Structure

7.1K
The pentose sugar in DNA is deoxyribose, while in RNA the pentose sugar is ribose. The difference between the sugars is the presence of the hydroxyl group on the ribose's second carbon and a hydrogen on the deoxyribose's second carbon. The phosphate residue attaches to the hydroxyl group of the 5′ carbon of one sugar and the hydroxyl group of the 3′ carbon of the sugar of the next nucleotide, which forms  a 5′ to 3′ phosphodiester linkage.
DNA Structure
DNA...
7.1K
RNA Stability01:53

RNA Stability

33.9K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.9K
Nucleic Acids02:43

Nucleic Acids

45.2K
Nucleic acids are the most important macromolecules for the continuity of life. They carry the cell's genetic blueprint and carry instructions for its functioning.
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
45.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Potential of Extracellular Vesicles Derived from Sheep Placenta in the Treatment of Skin Disorders.

ACS omega·2026
Same author

Ultrasensitive In Vivo Imaging of Adoptive Immune Cell Distribution and Expansion Using Second Near-Infrared Conjugated Oligoelectrolyte Probes.

Research (Washington, D.C.)·2026
Same author

Microenvironment-Adaptive Dynamic Hydrogel with Hierarchical Therapeutic Functions for Infected Chronic Wound Healing.

ACS applied materials & interfaces·2026
Same author

Sprayable asymmetric hydrogel prevents postoperative pleural adhesions via physical and biological dual therapy.

Materials today. Bio·2026
Same author

Non-genetically reprogrammed meta-neutrophils potentiate chemo-immunotherapy against lung metastatic triple-negative breast cancer.

Cell reports. Medicine·2026
Same author

Biomimetic trident lipid anchoring enables stable neutrophil-based combination therapy.

Journal of controlled release : official journal of the Controlled Release Society·2026

Related Experiment Video

Updated: Sep 12, 2025

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches
08:26

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches

Published on: May 1, 2018

9.5K

Effective RNA Delivery with Aggregation-Induced Lipid Backfolding.

Guan Wang1, Mengtong Wu1, Juanjuan Ye1

  • 1State Key Laboratory of Natural Medicines, China Pharmaceutical University, 639 Longmian Dadao, Jiangning District, Nanjing 211198, P. R. China.

ACS Nano
|August 5, 2025
PubMed
Summary

Lipid nanoparticles (LNPs) with asymmetric tails enhance RNA delivery by improving endosomal escape. This study provides design guidelines for ionizable lipids, optimizing LNP formulations for better RNA therapies.

Keywords:
asymmetric hydrocarbon tailsendosomal escapelipid backfoldinglipid nanoparticlesmembrane fusionmolecular dynamics simulations

More Related Videos

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.2K
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.6K

Related Experiment Videos

Last Updated: Sep 12, 2025

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches
08:26

Practical Use of RNA Interference: Oral Delivery of Double-stranded RNA in Liposome Carriers for Cockroaches

Published on: May 1, 2018

9.5K
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.2K
Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.6K

Area of Science:

  • Biochemistry and Molecular Biology
  • Materials Science
  • Drug Delivery Systems

Background:

  • Lipid nanoparticles (LNPs) are crucial for RNA delivery, but efficient endosomal escape remains a challenge.
  • Current strategies for LNP formulation rely on high-throughput screening without clear design principles for ionizable lipids.
  • Developing rational design guidelines for ionizable lipids is essential for advancing RNA-based therapies.

Purpose of the Study:

  • To propose a lipid structure-based strategy for guiding LNP formulation.
  • To investigate the role of asymmetric hydrocarbon tails in enhancing LNP endosomal escape.
  • To establish guidelines for designing ionizable lipids for improved RNA delivery.

Main Methods:

  • All-atom molecular dynamics simulations to study lipid-membrane interactions.
  • Design and formulation of LNPs with asymmetric-tailed lipids (L-Ada).
  • Membrane fusion experiments to validate simulation findings.
  • Development of a thermodynamic model for LNP design.

Main Results:

  • Asymmetric lipids, like L-Ada, induce lipid back-folding and membrane packing defects, facilitating membrane fusion.
  • A combined formulation of 20% L-Ada and 80% symmetric lipid L-Ste balances membrane defects and rigidity.
  • Optimized LNP formulation demonstrated enhanced membrane fusion capabilities.
  • A thermodynamic model provides specific design guidelines for ionizable lipids.

Conclusions:

  • LNPs incorporating asymmetrically tailed lipids show enhanced membrane fusion and endosomal escape.
  • The proposed lipid structure-based strategy offers a rational approach to LNP formulation.
  • This work provides a foundation for optimizing future LNP formulations for RNA therapies.